Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 6/20 | 0.35 |
| ▸ | RAB9A | P51151 | 5/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 8/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 4/20 | 0.32 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.32 |
| ▸ | CDK1 | P06493 | 2/20 | 0.32 |
| ▸ | CDK2 | P24941 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11911530 | 0.92 | CYP1A2 (0.39) | CYP1A2CYP2C9NPC1RAB9AKMT2A | |
| SCHEMBL13619062 | 0.89 | MEN1 (0.40) | CYP1A2NPC1RAB9AKMT2AL3MBTL1 | |
| SCHEMBL11911476 | 0.86 | CYP1A2 (0.34) | CYP1A2CYP2C9NPC1RAB9AKMT2A | |
| SCHEMBL13758603 | 0.84 | NPC1 (0.39) | CYP1A2CYP2C9NPC1RAB9AKMT2A | |
| SCHEMBL13432766 | 0.83 | NPC1 (0.38) | CYP1A2CYP2C9NPC1RAB9AKMT2A | |
| SCHEMBL12377654 | 0.82 | PRMT1 (0.49) | CYP1A2CYP2C9NPC1RAB9AMAPT | |
| SCHEMBL13088656 | 0.82 | PHLPP2 (0.38) | CYP1A2CYP2C9NPC1RAB9AKMT2A | |
| SCHEMBL14079901 | 0.82 | PTPN11 (0.32) | — | |
| SCHEMBL13619051 | 0.81 | MEN1 (0.42) | CYP1A2CYP2C9NPC1RAB9AKMT2A | |
| SCHEMBL13432711 | 0.81 | CYP1A2 (0.34) | CYP1A2CYP2C9NPC1RAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7619074-B2 | Reactive dyestuff with N,N-dialkylamino bridge group | EVERLIGHT USA, INC. (US) | 2009-11-17 | — | — | US | disclosed |
| US-20090176972-A1 | Novel reactive dyestuff with N,N-dialkylamino bridge group | EVERLIGHT USA, INC. (US) | 2009-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176972-A1 | Novel reactive dyestuff with N,N-dialkylamino bridge group | SRM, PADI1, NOS1 | CYP1A2 89/4885CYP2C9 1080/4885NPC1 2140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.